Myocardial In Vitro Platform for Drug Development and Cardiotoxicity Screening
Clemson University researchers have developed an in vitro myocardial therapy screening platform possessing superior physiological relevance that enables clinically translatable metrics for therapy efficacy and cardiotoxicity evaluation.Inventor: William Richardson, Samuel Coeyman, Jonathan G. Heywood
Published: 2/14/2022